IMS MAXIMS Comments on the Public Accounts Committee Hearing and NAO Report into NPfIT

IMS MAXIMSFollowing the recent UK Parliament Public Accounts Committee hearing and NAO (National Audit Office) Report, commenting Shane Tickell, CEO of UK clinical IT company IMS MAXIMS, said:

"Today's PAC committee hearing and last week's NAO report provide a damning picture of the National Programme from initial concept through to execution. By now the UK should have had among the best nationwide electronic patient record systems in the world. All that was needed was to set national standards and demand high levels of interoperability, then let trusts choose their own solution. This would have given smaller, more innovative suppliers the chance to provide hospitals with systems that worked and which met their real needs.

"Instead we seem to be in a position where - like the banks - the NPfIT contracts are seen as too big to be allowed to fail, and everyone else has to pay the price. This has left the Government trying to salvage a project which should have been abandoned, or completely re-engineered, long ago. The NHS and its patients have been severely let down.

"If the Government really wants an Information Revolution it should revitalise the drive for a nationwide electronic patient record systems and ease the terms and conditions so that bespoke suppliers in healthcare can compete, which ensures that clinicians have access to all relevant patient data in real time. There have been warm words about encouraging greater choice and creating more opportunities to new suppliers, but swift and decisive action is needed. If savings can be made from the remaining NPfIT contracts the money should be reinvested into helping trusts find the IT solutions they need. This relatively small-scale financial stimulus would do much to help patients, hospitals and the healthcare IT sector."

About IMS MAXIMS
IMS MAXIMS specialises in developing clinical and administrative software solutions and currently supports more than 100 organisations and 20,000 users of IMS MAXIMS products.

To find out more about IMS MAXIMS and its products visit www.imsmaxims.com.

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...